Abacavir sulfate

Abacavir sulfate (CAS 188062-50-2, EC 620-488-4) is a pharmaceutical-grade nucleoside reverse transcriptase inhibitor supplied as a sulfate salt. It is commercially recognised under trade names including Ziagen, Abamune, and Abavir. No E-code designation applies to this substance.

In pharmaceutical manufacturing, abacavir sulfate serves as an active pharmaceutical ingredient in antiretroviral formulations targeting HIV-1 infection, where it inhibits viral replication by competing with natural nucleosides. In personal care formulation research, it is evaluated as a skin conditioner functioning as a humectant, attracting and retaining moisture within the stratum corneum.

Abacavir sulfate is available in pharmaceutical-grade powder form, manufactured in compliance with Ph.Eur. monograph standards and subject to REACH registration requirements within the European market. Procurement is supported under HS code 2933595960. Packaging formats are available on request to meet GMP handling and storage specifications.